Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3481)
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
350
Price
$77.67
Total Value
$27.18K
Shares Held After
43,943
% of Holdings
0.8%
Viking Therapeutics, Inc. (VKTX)
FOEHR MATTHEW W — Director
Shares
16,000
Price
$35.11
Total Value
$561.69K
Shares Held After
132,036
% of Holdings
10.8%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Anzalone Christopher Richard — Director
Shares
5,771
Price
$66.39
Total Value
$383.14K
Shares Held After
3,792,739
% of Holdings
0.2%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
200
Price
$177.78
Total Value
$35.56K
Shares Held After
41,754
% of Holdings
0.5%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
9,125
Price
$177.17
Total Value
$1.62M
Shares Held After
41,954
% of Holdings
17.9%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
12,832
Price
$176.08
Total Value
$2.26M
Shares Held After
51,079
% of Holdings
20.1%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
34,103
Price
$175.17
Total Value
$5.97M
Shares Held After
63,911
% of Holdings
34.8%
INSMED Inc (INSM)
Schaeffer Orlov S Nicole — Chief People Strategy Officer
Shares
31,030
Price
$174.28
Total Value
$5.41M
Shares Held After
98,014
% of Holdings
24.0%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
893
Price
$82.93
Total Value
$74.06K
Shares Held After
23,393
% of Holdings
3.7%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
835
Price
$81.90
Total Value
$68.39K
Shares Held After
24,286
% of Holdings
3.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
8,122
Price
$80.71
Total Value
$655.53K
Shares Held After
25,121
% of Holdings
24.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
3,750
Price
$38.42
Total Value
$144.06K
Shares Held After
39,760
% of Holdings
8.6%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
7,433
Price
$12.85
Total Value
$95.49K
Shares Held After
0
% of Holdings
100.0%
Damora Therapeutics, Inc. (DMRA)
Firmani Lori — Chief Financial Officer
Shares
135
Price
$21.41
Total Value
$2.89K
Shares Held After
931
% of Holdings
12.7%
Damora Therapeutics, Inc. (DMRA)
Winslow Garrett — General Counsel
Shares
255
Price
$21.38
Total Value
$5.45K
Shares Held After
1,854
% of Holdings
12.1%
Damora Therapeutics, Inc. (DMRA)
Schambye Hans T. — Director
Shares
700
Price
$21.38
Total Value
$14.97K
Shares Held After
4,682
% of Holdings
13.0%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,595
Price
$39.57
Total Value
$102.68K
Shares Held After
12,965
% of Holdings
16.7%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,405
Price
$38.70
Total Value
$93.07K
Shares Held After
15,560
% of Holdings
13.4%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
4,432
Price
$40.43
Total Value
$179.19K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
13,055
Price
$4.20
Total Value
$54.79K
Shares Held After
46,945
% of Holdings
21.8%
GALECTIN THERAPEUTICS INC (GALT)
CALLICUTT JACK W — Chief Financial Officer
Shares
13,914
Price
$4.20
Total Value
$58.39K
Shares Held After
53,700
% of Holdings
20.6%
GALECTIN THERAPEUTICS INC (GALT)
LEWIS JOEL — Director
Shares
18,571
Price
$4.20
Total Value
$77.94K
Shares Held After
898,021
% of Holdings
2.0%
PTC THERAPEUTICS, INC. (PTCT)
STEELE GLENN JR MD PHD — Director
Shares
12,000
Price
$76.35
Total Value
$916.20K
Shares Held After
18,500
% of Holdings
39.3%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
18,338
Price
$79.27
Total Value
$1.45M
Shares Held After
30,453
% of Holdings
37.6%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
5,125
Price
$78.57
Total Value
$402.67K
Shares Held After
30,453
% of Holdings
14.4%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
70,037
Price
$35.87
Total Value
$2.51M
Shares Held After
69,188
% of Holdings
50.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
46
Price
$192.40
Total Value
$8.85K
Shares Held After
43,654
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
207
Price
$190.27
Total Value
$39.39K
Shares Held After
43,700
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
102
Price
$188.96
Total Value
$19.27K
Shares Held After
43,907
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
91
Price
$187.95
Total Value
$17.10K
Shares Held After
44,009
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
3,125
Price
$16.08
Total Value
$50.25K
Shares Held After
315,978
% of Holdings
1.0%
Bicycle Therapeutics plc (BCYC)
Lee Kevin — Director
Shares
10,325
Price
$6.80
Total Value
$70.21K
Shares Held After
629,985
% of Holdings
1.6%
Bicycle Therapeutics plc (BCYC)
Young Alethia — Chief Financial Officer
Shares
3,289
Price
$6.80
Total Value
$22.37K
Shares Held After
91,415
% of Holdings
3.5%
Bicycle Therapeutics plc (BCYC)
Milnes Alistair — CHIEF OPERATING OFFICER
Shares
3,244
Price
$6.80
Total Value
$22.06K
Shares Held After
140,133
% of Holdings
2.3%
Bicycle Therapeutics plc (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
2,827
Price
$6.80
Total Value
$19.22K
Shares Held After
100,275
% of Holdings
2.7%
Bicycle Therapeutics plc (BCYC)
Skynner Michael — CHIEF TECHNOLOGY OFFICER
Shares
3,045
Price
$6.80
Total Value
$20.71K
Shares Held After
165,232
% of Holdings
1.8%
Bicycle Therapeutics plc (BCYC)
Thompson Travis Alvin — CHIEF ACCOUNTING OFFICER
Shares
1,317
Price
$6.80
Total Value
$8.96K
Shares Held After
67,380
% of Holdings
1.9%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
4,080
Price
$75.20
Total Value
$306.82K
Shares Held After
187,371
% of Holdings
2.1%
Terns Pharmaceuticals, Inc. (TERN)
Kuriakose Emil — Chief Medical Officer
Shares
955
Price
$38.36
Total Value
$36.63K
Shares Held After
50,365
% of Holdings
1.9%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
1,295
Price
$16.70
Total Value
$21.63K
Shares Held After
25,000
% of Holdings
4.9%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
8,080
Price
$15.92
Total Value
$128.63K
Shares Held After
26,295
% of Holdings
23.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
100
Price
$32.39
Total Value
$3.24K
Shares Held After
671,907
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,191
Price
$31.79
Total Value
$69.65K
Shares Held After
672,007
% of Holdings
0.3%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
12,709
Price
$30.47
Total Value
$387.24K
Shares Held After
674,198
% of Holdings
1.9%
Terns Pharmaceuticals, Inc. (TERN)
Kuriakose Emil — Chief Medical Officer
Shares
200
Price
$39.60
Total Value
$7.92K
Shares Held After
51,320
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
21
Price
$186.59
Total Value
$3.92K
Shares Held After
44,100
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,920
Price
$74.13
Total Value
$142.33K
Shares Held After
191,451
% of Holdings
1.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$28.96
Total Value
$289.61K
Shares Held After
69,744
% of Holdings
12.5%
Fulcrum Therapeutics, Inc. (FULC)
Gould Robert J — Director
Shares
15,000
Price
$11.87
Total Value
$178.09K
Shares Held After
469,864
% of Holdings
3.1%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$38.48
Total Value
$769.65K
Shares Held After
80,000
% of Holdings
20.0%
Showing 3151–3200 of 3481 transactions (page 64 of 70)